Voyager Therapeutics
VYGR
#7465
Rank
โ‚น25.06 B
Marketcap
โ‚น458.79
Share price
1.31%
Change (1 day)
-17.96%
Change (1 year)

Revenue for Voyager Therapeutics (VYGR)

Revenue in 2024 (TTM): โ‚น11.97 Billion

According to Voyager Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚น12.14 Billion. In 2023 the company made a revenue of โ‚น20.81 Billion an increase over the revenue in the year 2022 that were of โ‚น3.38 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Voyager Therapeutics from 2015 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น11.97 B-42.47%
2023 โ‚น20.81 B514.86%
2022 โ‚น3.38 B21.56%
2021 โ‚น2.78 B-77.75%
2020 โ‚น12.51 B68.12%
2019 โ‚น7.44 B1297.35%
2018 โ‚น0.53 B-17.67%
2017 โ‚น0.64 B-33.04%
2016 โ‚น0.96 B-16.11%
2015 โ‚น1.15 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA